← All Sponsors
SPONSOR

Chulalongkorn University

Total Trials
4
Recruiting
4
Phases
N/A

Chulalongkorn University is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Critical Illness, Hyperpigmentation, ALS (Amyotrophic Lateral Sclerosis), Moderate to Severe Endodontic Pain.

Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Chulalongkorn University

How many clinical trials has Chulalongkorn University sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Chulalongkorn University, of which 4 are actively recruiting participants. These trials cover conditions including Critical Illness, Hyperpigmentation, ALS (Amyotrophic Lateral Sclerosis). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Chulalongkorn University research focus on?
Chulalongkorn University clinical trials span Critical Illness, Hyperpigmentation, ALS (Amyotrophic Lateral Sclerosis), Moderate to Severe Endodontic Pain. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Chulalongkorn University clinical trial?
To participate in a Chulalongkorn University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Chulalongkorn University trials with current recruitment status updated daily.

Clinical Trials by Chulalongkorn University

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology